Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Latin America, Middle East and Africa (LAMEA) Contrast Media Market, by Product Type
1.4.2 Latin America, Middle East and Africa (LAMEA) Contrast Media Market, by Application
1.4.3 Latin America, Middle East and Africa (LAMEA) Contrast Media Market, by Modality
1.4.4 Latin America, Middle East and Africa (LAMEA) Contrast Media Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : Sep, 2019–Mar, 2015) Leading Players
Chapter 4. LAMEA Contrast Media Market by Product Type
4.1 LAMEA Iodinated Market by Country
4.2 LAMEA Barium-based Market by Country
4.3 LAMEA Gadolinium-based Market by Country
4.4 LAMEA Microbubble Market by Country
Chapter 5. LAMEA Contrast Media Market by Application
5.1 LAMEA Neurological disorders Market by Country
5.2 LAMEA Cancer Market by Country
5.3 LAMEA Cardiovascular disorders Market by Country
5.4 LAMEA Gastrointestinal disorders Market by Country
5.5 LAMEA Nephrological disorders Market by Country
5.6 LAMEA Musculoskeletal disorders Market by Country
5.7 LAMEA Other Applications Market by Country
Chapter 6. LAMEA Contrast Media Market by Modality
6.1 LAMEA X-ray/CT Market by Country
6.2 LAMEA MRI Market by Country
6.3 LAMEA Ultrasound Market by Country
Chapter 7. LAMEA Contrast Media Market by Country
7.1 Brazil Contrast Media Market
7.1.1 Brazil Contrast Media Market by Product Type
7.1.2 Brazil Contrast Media Market by Application
7.1.3 Brazil Contrast Media Market by Modality
7.2 Argentina Contrast Media Market
7.2.1 Argentina Contrast Media Market by Product Type
7.2.2 Argentina Contrast Media Market by Application
7.2.3 Argentina Contrast Media Market by Modality
7.3 UAE Contrast Media Market
7.3.1 UAE Contrast Media Market by Product Type
7.3.2 UAE Contrast Media Market by Application
7.3.3 UAE Contrast Media Market by Modality
7.4 Saudi Arabia Contrast Media Market
7.4.1 Saudi Arabia Contrast Media Market by Product Type
7.4.2 Saudi Arabia Contrast Media Market by Application
7.4.3 Saudi Arabia Contrast Media Market by Modality
7.5 South Africa Contrast Media Market
7.5.1 South Africa Contrast Media Market by Product Type
7.5.2 South Africa Contrast Media Market by Application
7.5.3 South Africa Contrast Media Market by Modality
7.6 Nigeria Contrast Media Market
7.6.1 Nigeria Contrast Media Market by Product Type
7.6.2 Nigeria Contrast Media Market by Application
7.6.3 Nigeria Contrast Media Market by Modality
7.7 Rest of LAMEA Contrast Media Market
7.7.1 Rest of LAMEA Contrast Media Market by Product Type
7.7.2 Rest of LAMEA Contrast Media Market by Application
7.7.3 Rest of LAMEA Contrast Media Market by Modality
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals:
8.2 General Electric (GE) Co. (GE Healthcare)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 The Guerbet Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Product Launches and Product Expansions:
8.4 Lantheus Holdings, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Bracco S.p.A.
8.5.1 Company Overview
8.5.2 Regional Analysis
8.5.3 Recent strategies and developments:
8.5.3.1 Product Launches and Product Expansions:
8.5.3.2 Acquisition and Mergers:
8.5.3.3 Approvals:
8.6 Trivitron Healthcare Pvt. Ltd.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 Nano Therapeutics Pvt. Ltd.
8.7.1 Company Overview
8.8 Magnus Health, LLC (Veracross LLC)
8.8.1 Company Overview
8.9 Imax Diagnostic Imaging Limited
8.9.1 Company Overview
8.1 Daiichi Sankyo Company, Limited
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 